Cohbar Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Cohbar Inc.

Cohbar Inc. | Mutual Funds

Mutual Funds that own Cohbar Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Vanguard Total Stock Market Index Fund

735,402

1.73%

13,150

07/31/2018

iShares Russell 2000 ETF

467,097

1.1%

-249

0.01%

09/06/2018

Vanguard Extended Market Index Fund

378,132

0.89%

07/31/2018

iShares Russell 2000 Growth ETF

219,534

0.52%

0.01%

09/06/2018

Fidelity Spartan Extended Market Index Fund

100,015

0.24%

07/31/2018

Fidelity Spartan Total Market Index Fund

86,892

0.21%

07/31/2018

iShares Micro Cap ETF

60,081

0.14%

0.03%

09/06/2018

Vanguard Institutional Total Stock Market Index Fund

41,948

0.1%

07/31/2018

Schwab Small Cap Index Fund

41,500

0.1%

41,500

0.01%

06/30/2018

39,470

0.09%

0.01%

07/31/2018

About Cohbar

View Profile

Address	1455 Adams Drive Pasadena California 94025 United States
Employees	-
Website	http://www.cohbar.com
Updated	07/08/2019
CohBar, Inc. engages in the research and development of mitochondria-based therapeutics. It focuses on treatments of diseases, which include diabetes, obesity, fatty liver disease and non-alcoholic steatohepatitis, cancer, Alzheimer's disease, and atherosclerosis. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Pasadena, CA.